DOI: http://dx.doi.org/10.18203/2349-3933.ijam20173241

Role of depression, anxiety, testosterone and luteinizing hormone levels in disorders of sexual function

Nagendar Reddy Jakka, Jayanthy Ramesh

Abstract


Background: Hypogonadism as well as deficiency of testosterone can lead to disorder of sexual function in males. The initial clinical manifestations of this are mostly erectile dysfunction (ED) and hypoactive sexual desire disorder (HSSD). This not only causes the sexual dysfunction but can also lead to many health problems. To study the role of depression, anxiety, testosterone and luteinizing hormone levels in disorders of sexual function

Methods: A hospital based cross sectional study was conducted at department of General Medicine, Kamineni Academy of Medical Sciences, Hyderabad for a period of one year among 60 eligible study subjects to study the role of depression, anxiety, testosterone and luteinizing hormone levels in disorders of sexual function. All male patients aged between 21-60 years, who had stable heterosexual relationship, were included. Patients with severe diseases, users of alcohol and smoking, having marital disharmony were excluded. Informed consent was obtained from all the patients.

Results: Testosterone and LH levels are significantly lower in subjects with SD, suggesting that a state of hypogonadotropic hypogonadism prevails in male diabetics with SD. Depression and anxiety are significant factors associated with SD. Premature Ejaculation is significantly associated with Anxiety.

Conclusions: Testosterone and LH levels are significantly lower in subjects with SD. Depression and anxiety is significant factors associated with SD. Premature Ejaculation is significantly associated with anxiety.


Keywords


Luteinizing hormone, Metabolic disorder, Testosterone

Full Text:

PDF

References


Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, et al. Endocrine aspects of male sexual dysfunctions. J Sexual Med. 2010;7(4pt2):1627-56.

Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, et al. Type 2 diabetes mellitus and testosterone: A meta‐analysis study. Int J Androl. 2011;34(6pt1):528-40.

Veves A, Webster L, Chen TF, Payne S, Boulton AJ. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabetic Med. 1995;12(1):77-82.

Baldwin DS. Depression and sexual function. J Psychopharmacol. 1996;10(Suppl 1):S30-4.

Sugimori H, Yoshida K, Tanaka T, Baba K, Nishida T, Nakazawa R, et al. PSYCHOLOGY: Relationships between Erectile Dysfunction, Depression, and Anxiety in Japanese Subjects. J Sexual Med. 2005;2(3):390-6.

Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Fernando DJ, Levy JC. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. The J Sexual Med. 2008;5(9):2125-34.

Segraves RT. Management of hypoactive sexual desire disorder. Adv Psychosom Med. 2008;29:23-32.

Sexton WJ, Jarow JP. Effect of diabetes mellitus upon male reproductive function. Urol. 1997;49:508-13.

Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression. Archives General Psych. 1985;42(11):1098-104.

Mathew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav. 1982;11:323-5.

Angst J. Sexual problems in healthy and depressed patients. Int Clin Psychopharmacol. 1998;13(Suppl6):S1-3.

Baldwin DS. Depression and sexual function. J Psychopharmacol. 1996;10(Suppl 1):S30-4.

Kaplan HS. Anxiety and sexual dysfunction. J Clin Psych. 1988;49:21-5.

Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little Brown and Co; 1970.

Shamloul R. Management of honeymoon impotence. J Sex Med. 2006;3:361-366.

Mallis D, Moysidis K, Nakopoulou E, Papaharitou S, Hatzimouratidis K, Hatzichristou D. Psychiatric morbidity is frequently undetected in patients with erectile dysfunction. J Urol. 2005;174(5):1913-6.

Dunn KM, Croft PR, Hackett GI. Association of sexual problem with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemol Community Health. 1999;53:144-8.

Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev. 1987;8(1):1-28.

Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002;25(1):55-60.

Lange JD, Brown WA, Wincze JP, Zwick W. Serum testosterone concentration and penile tumescence changes in men. Hormones and Behavior. 1980;14(3):267-70.

Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metabol. 1983;57(3):557-62.

Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, MacIsaac RJ, Clarke S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metabol. 2008;93(5):1834-40.

Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes care. 2010;33(6):1186-92.

Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes care. 2007;30(4):911-7.

Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P. Testosterone concentration in young patients with diabetes. Diabetes Care. 2008;31:2013-17.

Tomar R, Dhindsa S, Chaudhuri A, Mohanty P, Garg R, Dandona P. Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes care. 2006;29(5):1120-2.

Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, MacIsaac RJ, Clarke S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metabol. 2008;93(5):1834-40.

Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2008;24(Suppl 2):S56-S58.

Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:1995-2010.